|
FDA begins manufacturing practices initiative.
September 23, 2002 8:53am
08/26/2002
|
Advertisement: Explore Within This Space |
 |
|
|
|
|
The FDA has begun a major programme to upgrade and modernize its
GMP requirement for drugs. The review will cover the production of
veterinary and human drugs, including biological products and
vaccines. The aim will be to make production processes consistent
and safer. There are three goals. These are to focus more on
processes that present actual risks to public health; establish
quality standards that do not impede innovation or the introduction
of new technologies; and to enhance the predictability in FDA's
approach to quality and safety. The matter is important to the drug
industry, because several drug makers have recently been charged
with infringements and received fines.
Copyright 2002. All Rights Reserved.
Financial Times Information Limited - Asia Africa Intelligence
Wire
Copyright © 2002 Financial Times
Limited, All Rights Reserved
|
